Zenas Bio inks potential $2 billion licensing deal with China's InnoCare for autoimmune drug

reuters.com/business/healthcare-pharmaceuticals/zenas-bio-inks-potential-2-billion-licensing-deal-with-chinas-innocare-2025-10-08

This story appeared on reuters.com, 2025-10-08 10:04:22.864000.
The Entire Business World on a Single Page. Free to Use →